1
|
Riquin E, Duverger P, Cariou C, Barth M, Prouteau C, Van Bogaert P, Bonneau D, Roy A. Neuropsychological and Psychiatric Features of Children and Adolescents Affected With Mitochondrial Diseases: A Systematic Review. Front Psychiatry 2020; 11:747. [PMID: 32848925 PMCID: PMC7399331 DOI: 10.3389/fpsyt.2020.00747] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Accepted: 07/16/2020] [Indexed: 11/16/2022] Open
Abstract
UNLABELLED Mitochondrial diseases (MDs) are a group of clinically heterogeneous genetic disorders that arise as the result of dysfunctional mitochondria. Only few medical articles deal with neuropsychological or psychiatric aspects of MDs. AIM The present article aims to provide a systematic review of neuropsychological and psychiatric aspects of MDs. METHODS In order to identify all studies dealing with psychiatric and neuropsychological aspects of MDs in children and adolescents, we performed a search in the medical literature between April 2009 and April 2019 using PubMed, Cochrane, and Web of Science and we defined inclusion and exclusion criteria. RESULTS We found only seven studies that satisfy the inclusion requirements and criteria. The main psychiatric aspects reported in MDs were depressive and behavioral disorders. With regard to the neuropsychological aspects of MDs, developmental analyses showed an overall deterioration and developmental delay. INTERPRETATION Children and adolescents with MDs may present psychiatric symptoms and neuropsychological impairment. A more systematic investigation of psychiatric and neuropsychological features of MDs is needed to foster a better understanding of the phenotype of these diseases and their links with the genotype, which may have significant implications for the developmental trajectories of patients.
Collapse
Affiliation(s)
- Elise Riquin
- Department of Child and Adolescent Psychiatry, University Hospital of Angers, Angers, France.,Mitovasc Unit, UMR CNRS 6015-INSERM 1083, Angers, France.,Laboratory of Psychology, LPPL EA4638, University of Angers, Angers, France
| | - Philippe Duverger
- Department of Child and Adolescent Psychiatry, University Hospital of Angers, Angers, France.,Laboratory of Psychology, LPPL EA4638, University of Angers, Angers, France
| | - Cindy Cariou
- Department of Child and Adolescent Psychiatry, University Hospital of Angers, Angers, France
| | - Magalie Barth
- Department of Biochemistry and Genetics, University Hospital of Angers, Angers, France
| | - Clément Prouteau
- Department of Biochemistry and Genetics, University Hospital of Angers, Angers, France
| | - Patrick Van Bogaert
- Department of Pediatric Neurology, Angers University Hospital, Angers, France
| | - Dominique Bonneau
- Mitovasc Unit, UMR CNRS 6015-INSERM 1083, Angers, France.,Department of Biochemistry and Genetics, University Hospital of Angers, Angers, France
| | - Arnaud Roy
- Laboratory of Psychology, LPPL EA4638, University of Angers, Angers, France.,Reference Center for Learning Disabilities, Nantes University Hospital, Nantes, France
| |
Collapse
|
2
|
Gonçalves VF, Cappi C, Hagen CM, Sequeira A, Vawter MP, Derkach A, Zai CC, Hedley PL, Bybjerg-Grauholm J, Pouget JG, Cuperfain AB, Sullivan PF, Christiansen M, Kennedy JL, Sun L. A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia. Biol Psychiatry 2018; 83:780-789. [PMID: 29628042 PMCID: PMC7168759 DOI: 10.1016/j.biopsych.2018.02.1175] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2017] [Revised: 02/26/2018] [Accepted: 02/27/2018] [Indexed: 12/14/2022]
Abstract
BACKGROUND The genetic risk factors of schizophrenia (SCZ), a severe psychiatric disorder, are not yet fully understood. Multiple lines of evidence suggest that mitochondrial dysfunction may play a role in SCZ, but comprehensive association studies are lacking. We hypothesized that variants in nuclear-encoded mitochondrial genes influence susceptibility to SCZ. METHODS We conducted gene-based and gene-set analyses using summary association results from the Psychiatric Genomics Consortium Schizophrenia Phase 2 (PGC-SCZ2) genome-wide association study comprising 35,476 cases and 46,839 control subjects. We applied the MAGMA method to three sets of nuclear-encoded mitochondrial genes: oxidative phosphorylation genes, other nuclear-encoded mitochondrial genes, and genes involved in nucleus-mitochondria crosstalk. Furthermore, we conducted a replication study using the iPSYCH SCZ sample of 2290 cases and 21,621 control subjects. RESULTS In the PGC-SCZ2 sample, 1186 mitochondrial genes were analyzed, among which 159 had p values < .05 and 19 remained significant after multiple testing correction. A meta-analysis of 818 genes combining the PGC-SCZ2 and iPSYCH samples resulted in 104 nominally significant and nine significant genes, suggesting a polygenic model for the nuclear-encoded mitochondrial genes. Gene-set analysis, however, did not show significant results. In an in silico protein-protein interaction network analysis, 14 mitochondrial genes interacted directly with 158 SCZ risk genes identified in PGC-SCZ2 (permutation p = .02), and aldosterone signaling in epithelial cells and mitochondrial dysfunction pathways appeared to be overrepresented in this network of mitochondrial and SCZ risk genes. CONCLUSIONS This study provides evidence that specific aspects of mitochondrial function may play a role in SCZ, but we did not observe its broad involvement even using a large sample.
Collapse
Affiliation(s)
- Vanessa F Gonçalves
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
| | - Carolina Cappi
- Department of Psychiatry, University of São Paulo, School of Medicine, Brazil
| | - Christian M Hagen
- Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
| | - Adolfo Sequeira
- Department of Psychiatry and Human Behavior, University of California, Irvine, USA
| | - Marquis P Vawter
- Department of Psychiatry and Human Behavior, University of California, Irvine, USA
| | - Andriy Derkach
- Department of Statistical Sciences, Faculty of Arts and Science, University of Toronto, Toronto, Canada
| | - Clement C Zai
- Department of Psychiatry, University of Toronto, Toronto, Canada,Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Canada
| | - Paula L Hedley
- Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
| | | | - Jennie G Pouget
- Department of Psychiatry, University of Toronto, Toronto, Canada,Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Canada
| | - Ari B. Cuperfain
- Department of Psychiatry, University of Toronto, Toronto, Canada,Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Canada
| | - Patrick F Sullivan
- Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA;,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Michael Christiansen
- Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark,Department of Biomedical Science, University of Copenhagen, Copenhagen, Denmark
| | - James L Kennedy
- Department of Psychiatry, University of Toronto, Toronto, Canada,Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Canada,Corresponding author: Vanessa F Gonçalves ()
| | - Lei Sun
- Department of Statistical Sciences, Faculty of Arts and Science, University of Toronto, Toronto, Canada,Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada,Corresponding author: Vanessa F Gonçalves ()
| |
Collapse
|
3
|
Rosebush PI, Anglin RE, Rasmussen S, Mazurek MF. Mental illness in patients with inherited mitochondrial disorders. Schizophr Res 2017; 187:33-37. [PMID: 28545943 DOI: 10.1016/j.schres.2017.05.010] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/24/2017] [Revised: 05/04/2017] [Accepted: 05/07/2017] [Indexed: 12/30/2022]
Affiliation(s)
- P I Rosebush
- Department of Psychiatry and Behavioural Neuroscience, McMaster University, Canada; MiNDS Graduate Programme, McMaster University, Canada; Biomedical Sciences Graduate Programme, McMaster University, Canada.
| | - R E Anglin
- Department of Psychiatry and Behavioural Neuroscience, McMaster University, Canada; Department of Medicine, Division of Neurology, McMaster University, Canada; MiNDS Graduate Programme, McMaster University, Canada; Biomedical Sciences Graduate Programme, McMaster University, Canada
| | - S Rasmussen
- MiNDS Graduate Programme, McMaster University, Canada
| | - M F Mazurek
- Department of Psychiatry and Behavioural Neuroscience, McMaster University, Canada; Department of Medicine, Division of Neurology, McMaster University, Canada; MiNDS Graduate Programme, McMaster University, Canada; Biomedical Sciences Graduate Programme, McMaster University, Canada
| |
Collapse
|
4
|
Abstract
Mitochondrial diseases are a clinically heterogeneous group of disorders that ultimately result from dysfunction of the mitochondrial respiratory chain. There is some evidence to suggest that mitochondrial dysfunction plays a role in neuropsychiatric illness; however, the data are inconclusive. This article summarizes the available literature published in the area of neuropsychiatric manifestations in both children and adults with primary mitochondrial disease, with a focus on autism spectrum disorder in children and mood disorders and schizophrenia in adults.
Collapse
Affiliation(s)
- Samantha E Marin
- Department of Neurosciences, University of California, San Diego (UCSD), 9500 Gilman Drive #0935, La Jolla, CA 92093-0935, USA
| | - Russell P Saneto
- Department of Neurology, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way Northeast, Seattle, WA 98105, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way Northeast, Seattle, WA 98105, USA.
| |
Collapse
|
5
|
Long Z, Dyke JP, Ma R, Huang CC, Louis ED, Dydak U. Reproducibility and effect of tissue composition on cerebellar γ-aminobutyric acid (GABA) MRS in an elderly population. NMR IN BIOMEDICINE 2015; 28:1315-23. [PMID: 26314380 PMCID: PMC4594865 DOI: 10.1002/nbm.3381] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/15/2015] [Revised: 07/22/2015] [Accepted: 07/24/2015] [Indexed: 05/06/2023]
Abstract
MRS provides a valuable tool for the non-invasive detection of brain γ-aminobutyric acid (GABA) in vivo. GABAergic dysfunction has been observed in the aging cerebellum. The study of cerebellar GABA changes is of considerable interest in understanding certain age-related motor disorders. However, little is known about the reproducibility of GABA MRS in an aged population. Therefore, this study aimed to explore the feasibility and reproducibility of GABA MRS in the aged cerebellum at 3.0 T and to examine the effect of differing tissue composition on GABA measurements. MRI and (1)H MRS examinations were performed on 10 healthy elderly volunteers (mean age, 75.2 ± 6.5 years) using a 3.0-T Siemens Tim Trio scanner. Among them, five subjects were scanned twice to assess the short-term reproducibility. The MEGA-PRESS (Mescher-Garwood point-resolved spectroscopy) J-editing sequence was used for GABA detection in two volumes of interest (VOIs) in the left and right cerebellar dentate. MRS data processing and quantification were performed with LCModel 6.3-0L using two separate basis sets, generated from density matrix simulations using published values for chemical shifts and J couplings. Raw metabolite levels from LCModel outputs were corrected for cerebrospinal fluid contamination and relaxation. GABA-edited spectra yielded robust and stable GABA measurements with averaged intra-individual coefficients of variation for corrected GABA+ between 4.0 ± 2.8% and 13.4 ± 6.3%, and inter-individual coefficients of variation between 12.6% and 24.2%. In addition, there was a significant correlation between GABA+ obtained with the two LCModel basis sets. Overall, our results demonstrated the feasibility and reproducibility of cerebellar GABA-edited MRS at 3.0 T in an elderly population. This information might be helpful for studies using this technique to study GABA changes in normal or diseased aging brain, e.g. for power calculations and the interpretation of longitudinal observations.
Collapse
Affiliation(s)
- Zaiyang Long
- Department of Radiology, Mayo Clinic, Rochester, MN, USA
| | - Jonathan P. Dyke
- Department of Radiology, Weill Cornell Medical College, New York, NY, USA
| | - Ruoyun Ma
- School of Health Sciences, Purdue University, West Lafayette, IN, USA
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Chaorui C. Huang
- Brain and Mind Research Institute, Weill Medical College of Cornell University, New York, NY, USA
| | - Elan D. Louis
- Department of Neurology, Yale School of Medicine, Yale University, New Haven, CT, USA
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT, USA
| | - Ulrike Dydak
- School of Health Sciences, Purdue University, West Lafayette, IN, USA
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
- Correspondence to: U. Dydak, School of Health Sciences, Purdue University, West Lafayette, IN, 47907, USA.
| |
Collapse
|